Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Introducing Trial Size Antibodies from BioVision: An Affordable Solution to Screen Multiple Targets!
April 2016  |  Press Releases
BioVision is releasing hundreds of best performing Trail size antibodies to meet all your early stage research needs.
Read More
Introducing BioVision's New Fabulously Active (FabAct™) Proteinase K!
January 2016  |  Press Releases
BioVision proudly announces the launch of the Molecular Bology Grade Fabulously Active FabAct™ Proteinase K (recombinant), which is the most powerful proteinase among all proteinases characterized so far.
Read More
BioVision Inc, Announces The Launch Of A Multidrug Resistance Assay Kit
January 2016  |  Press Releases
BioVision, Inc., proudly announces the launch of a Multidrug Resistance Assay Kit. The assay can be HTP adaptable and does not require special equipment.
Read More
Studying Exosome has never been so user friendly! Introducing New Exosome Products from Biovision!
January 2016  |  Press Releases
Biovision proudly announces the launch of a wide selection of products dedicated to exosome research.
Read More
Fast, efficient and super sensitive fluorescent based assay kit for screening of PPARy ligands
January 2016  |  Press Releases
BioVision, Inc. proudly announces the launch of the first fluorometric PPARγ Ligand Screening/Characterization Assay Kit.
Read More